Company profile
SEAL Therapeutics AG
SEAL Therapeutics develops its innovative gene therapy as a potential treatment for severe muscular dystrophy
- Industry
- Biotechnology
- Employees
- 3
- Headquarters
- Basel
- Founded
- 2021
- Office locations
- 1
SEAL Therapeutics AG company summary
SEAL Therapeutics AG is a company in the Biotechnology industry, headquartered in Basel, founded in 2021. On LinkedIn the company has around 3 employees.
What technology does SEAL Therapeutics AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About SEAL Therapeutics AG
SEAL Therapeutics is developing its proprietary SEAL technology as a potential gene therapy for laminin-α2 deficient congenital muscular dystrophy (LAMA2 MD), a severe and progressive neuromuscular disease affecting children from birth. SEAL Therapeutics aims to team-up with and support a qualified pharma partner with experience in advanced gene therapy technologies for clinical development to ultimately make this innovative treatment approach available to patients.
Where is SEAL Therapeutics AG located?
SEAL Therapeutics AG lists 1 location.
Compare companies similar to SEAL Therapeutics AG
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
SEAL Therapeutics AG sealtherapeutics.com | Biotechnology | 3 | 2021 | Basel |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about SEAL Therapeutics AG
What does SEAL Therapeutics AG do?
SEAL Therapeutics is developing its proprietary SEAL technology as a potential gene therapy for laminin-α2 deficient congenital muscular dystrophy (LAMA2 MD), a severe and progressive neuromuscular disease affecting children from birth. SEAL Therapeutics aims to team-up with and support a qualified pharma partner with experience in advanced gene therapy technologies for clinical development to ultimately make this innovative treatment approach available to patients.
How many employees does SEAL Therapeutics AG have?
SEAL Therapeutics AG has around 3 employees on LinkedIn.
Where is SEAL Therapeutics AG headquartered?
SEAL Therapeutics AG is headquartered in Basel.
When was SEAL Therapeutics AG founded?
SEAL Therapeutics AG was founded in 2021.
Build a lead list from companies like SEAL Therapeutics AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.